Imagine Donna Reid’s elation last year when she learned of a new state law that could save her almost $1,500 annually. Signed by Gov. Ralph Northam a year ago, the measure enacted by the Virginia ...

Levemir (insulin detemir) is safe to receive while pregnant or breastfeeding. However, factors such as the form you get or the condition the drug helps treat may determine whether you should receive ...

Levemir (insulin detemir) is a brand-name injection that’s prescribed for diabetes. Levemir has interactions with alcohol, some other drugs, and certain supplements. Examples include beta-blockers and ...

CRAWFORDSVILLE, Ind. (WISH) — For 13 years, Molly King has depended on an insulin drug to manage her Type 1 diabetes. On Dec. 31, that drug will be wiped from the market. King, who lives in ...

As a special education teacher living with Type 1 diabetes in Crawfordsville, I’ve relied on insulin to manage my condition since my diagnosis in 2011. Despite my engagement as an #insulin4all ...

LONDON/WASHINGTON (Reuters) - Novo Nordisk's decision to stop selling its long-acting insulin Levemir in the United States has left some diabetes patients struggling to switch treatments, patients and ...

Senate Democrats are meeting with Novo Nordisk executives to address the decision to stop selling a long-acting insulin in the country; research is attempting to prove the health benefits of new ...

Novo Nordisk (NVO) is reportedly set to meet with U.S. Senate aides on Tuesday to discuss why the drugmaker is discontinuing marketing its long-acting insulin Levemir in the U.S. The Danish drugmaker ...

This leaflet answers some common questions about Levemir ® FlexPen ®. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All ...

This leaflet answers some common questions about Levemir ® Penfill ®. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All ...

A year ago, when Novo Nordisk announced it would cut the price of multiple insulin products by up to 75%, President Biden, lawmakers, and patient groups all counted the move as a win. But several ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning! Today we have some developments about Novo Nordisk’s insulin ...